• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用前列环素类似物伊洛前列素持续输注治疗肺动脉高压。

Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.

作者信息

Higenbottam T W, Butt A Y, Dinh-Xaun A T, Takao M, Cremona G, Akamine S

机构信息

Department of Medicine and Pharmacology, School of Medicine, University of Sheffield, UK.

出版信息

Heart. 1998 Feb;79(2):175-9. doi: 10.1136/hrt.79.2.175.

DOI:10.1136/hrt.79.2.175
PMID:9538312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1728597/
Abstract

OBJECTIVE

To compare prostacyclin with an analogue, iloprost, in treatment of severe pulmonary hypertension.

PATIENTS

Eight patients with severe pulmonary hypertension: primary in five, thromboembolic pulmonary hypertension in three.

METHODS

All patients underwent right heart catheterisation. Mean (SEM) right atrial pressure was 9.9 (2.2) mm Hg, mean pulmonary artery pressure 67.4 (3.0) mm Hg, cardiac index 1.75 (0.13) l/min/m2 and mixed venous oxygen saturation 59.1(3.1)%. Continuous intravenous epoprostenol (prostacyclin, PGI2) or iloprost was given for phase I (three to six weeks); the patients were then crossed over to receive the alternate drug in an equivalent phase II.

MAIN OUTCOME MEASURES

Exercise tolerance was measured at baseline and at the end of phase I and II with a 12 minute walk; distance covered, rest period, percentage drop in arterial oxygen saturation (delta Sao2%) and percentage rise in heart rate (delta HR%).

RESULTS

Walking distance covered rose from (mean (SEM)) 407.5 (73) to 591 (46) m with PGI2 (p = 0.004) and to 602.5 (60) m while on iloprost (p = 0.008). Rest period decreased from 192 (73) seconds at baseline to 16 (16) seconds with PGI2 (p = 0.01) and to 58 (34) seconds with iloprost (p = 0.008). Delta HR% was 37.5(6)% at baseline, 35(3)% on PGI2, and 24(6)% on iloprost (p = 0.04).

CONCLUSIONS

Both intravenous PGI2 and iloprost caused significant improvement in exercise tolerance. Iloprost offers an alternative to PGI2 treatment of severe pulmonary hypertension.

摘要

目的

比较前列环素及其类似物伊洛前列素治疗重度肺动脉高压的效果。

患者

8例重度肺动脉高压患者,其中原发性肺动脉高压5例,血栓栓塞性肺动脉高压3例。

方法

所有患者均接受右心导管检查。平均(标准误)右心房压力为9.9(2.2)mmHg,平均肺动脉压力为67.4(3.0)mmHg,心脏指数为1.75(0.13)l/min/m²,混合静脉血氧饱和度为59.1(3.1)%。在第一阶段(3至6周)持续静脉输注依前列醇(前列环素,PGI2)或伊洛前列素;然后患者交叉接受另一药物进行为期相当的第二阶段治疗。

主要观察指标

在基线时以及第一阶段和第二阶段结束时,通过12分钟步行试验测量运动耐量;测量步行距离、休息时间、动脉血氧饱和度下降百分比(ΔSao2%)和心率上升百分比(ΔHR%)。

结果

使用PGI2时,步行距离从(平均(标准误))407.5(73)米增加到591(46)米(p = 0.004),使用伊洛前列素时增加到602.5(60)米(p = 0.008)。休息时间从基线时的192(73)秒减少到使用PGI2时的16(16)秒(p = 0.01),使用伊洛前列素时减少到58(34)秒(p = 0.008)。ΔHR%在基线时为37.5(6)%,使用PGI2时为35(3)%,使用伊洛前列素时为24(6)%(p = 0.04)。

结论

静脉输注PGI2和伊洛前列素均能显著改善运动耐量。伊洛前列素为重度肺动脉高压的治疗提供了一种替代PGI2的选择。

相似文献

1
Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost.使用前列环素类似物伊洛前列素持续输注治疗肺动脉高压。
Heart. 1998 Feb;79(2):175-9. doi: 10.1136/hrt.79.2.175.
2
[Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].吸入性前列环素和伊洛前列素治疗继发于肺纤维化的重度肺动脉高压
Pneumologie. 2000 Mar;54(3):133-42. doi: 10.1055/s-2000-9076.
3
Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.原发性肺动脉高压中血管舒张反应的评估。比较通过输注或吸入给予的前列环素和依洛前列素。
Eur Heart J. 2003 Feb;24(4):356-65. doi: 10.1016/s0195-668x(02)00302-0.
4
Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension.静脉注射伊洛前列素治疗雾化吸入伊洛前列素在肺动脉高压中治疗失败的情况。
Eur Respir J. 2002 Aug;20(2):339-43. doi: 10.1183/09031936.02.02462001.
5
Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.雾化吸入前列环素和依洛前列素治疗重度肺动脉高压
Ann Intern Med. 1996 May 1;124(9):820-4. doi: 10.7326/0003-4819-124-9-199605010-00006.
6
Long-term treatment of pulmonary hypertension with aerosolized iloprost.雾化吸入伊洛前列素治疗肺动脉高压的长期疗效
Eur Respir J. 2001 Jan;17(1):8-13. doi: 10.1183/09031936.01.17100080.
7
The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension.合成前列环素类似物伊洛前列素对原发性肺动脉高压的急性作用。
Br J Clin Pract. 1990 Jun;44(6):231-4.
8
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.用伊洛前列素气雾剂(一种前列环素类似物)对原发性肺动脉高压进行长期治疗。
N Engl J Med. 2000 Jun 22;342(25):1866-70. doi: 10.1056/NEJM200006223422503.
9
[Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].[在合并结缔组织病的肺动脉高压患者中通过急性血管扩张试验比较腺苷与伊洛前列素]
Zhonghua Yi Xue Za Zhi. 2009 Aug 11;89(30):2099-102.
10
[Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].前列环素治疗肺动脉高压的现状与未来展望——静脉、皮下、吸入及口服前列环素类似物
Nihon Rinsho. 2001 Jun;59(6):1132-8.

引用本文的文献

1
The Use of an Inspiration-Synchronized Vibrating Mesh Nebulizer for Prolonged Inhalative Iloprost Administration in Mechanically Ventilated Patients-An In Vitro Model.在机械通气患者中使用吸气同步振动网式雾化器进行伊洛前列素的长时间吸入给药——体外模型
Pharmaceutics. 2023 Aug 3;15(8):2080. doi: 10.3390/pharmaceutics15082080.
2
Prostacyclin for pulmonary arterial hypertension.前列环素用于肺动脉高压
Cochrane Database Syst Rev. 2019 May 1;5(5):CD012785. doi: 10.1002/14651858.CD012785.pub2.
3
Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension.6 分钟步行试验对肺动脉高压患者脑利钠肽前体水平的影响。
Lung. 2018 Jun;196(3):315-319. doi: 10.1007/s00408-018-0111-0. Epub 2018 Mar 21.
4
Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension.静脉注射伊洛前列素治疗肺动脉高压患者的中心静脉导管相关血流感染。
Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):883-9. doi: 10.1007/s10096-013-1822-z. Epub 2013 Feb 7.
5
Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy.静脉注射伊洛前列素治疗非肠外治疗恶化的特发性肺动脉高压患者的长期疗效。
BMC Pulm Med. 2011 Dec 1;11:56. doi: 10.1186/1471-2466-11-56.
6
"Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation.肺动脉高压的“达标治疗”以及体外膜肺氧合作为移植过渡手段的应用
Eur Respir Rev. 2011 Dec;20(122):297-300. doi: 10.1183/09059180.00005511.
7
Diagnostic and therapeutic algorithm for pulmonary arterial hypertension.肺动脉高压的诊断与治疗流程
Pulm Circ. 2011 Jan-Mar;1(1):122-4. doi: 10.4103/2045-8932.78096.
8
Treatment of pulmonary arterial hypertension with targeted therapies.肺动脉高压的靶向治疗。
Nat Rev Cardiol. 2011 Jul 19;8(9):526-38. doi: 10.1038/nrcardio.2011.104.
9
Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertension.预防肺动脉高压大鼠模型支气管高反应性的研究。
Respir Res. 2011 Apr 27;12(1):58. doi: 10.1186/1465-9921-12-58.
10
Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.慢性血栓栓塞性肺动脉高压的诊断评估与管理:临床实践指南。
Can Respir J. 2010 Nov-Dec;17(6):301-34. doi: 10.1155/2010/704258.

本文引用的文献

1
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.持续静脉输注依前列醇(前列环素)与常规疗法治疗原发性肺动脉高压的比较。
N Engl J Med. 1996 Feb 1;334(5):296-301. doi: 10.1056/NEJM199602013340504.
2
Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.前列环素(依前列醇)与心肺移植治疗重度肺动脉高压
Br Heart J. 1993 Oct;70(4):366-70. doi: 10.1136/hrt.70.4.366.
3
Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.原发性肺动脉高压患者长期持续静脉输注前列环素后的生存情况
Ann Intern Med. 1994 Sep 15;121(6):409-15. doi: 10.7326/0003-4819-121-6-199409150-00003.
4
Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases.结缔组织病患者严重肺动脉高压的长期伊洛前列素输注治疗
Arthritis Rheum. 1994 Oct;37(10):1528-33. doi: 10.1002/art.1780371018.
5
Measurement of circulating prostacyclin.循环前列环素的测量
Nature. 1981 Jul 23;292(5821):364-6. doi: 10.1038/292364a0.
6
Hemodynamic effects of iloprost, a prostacyclin analog.前列环素类似物伊洛前列素的血流动力学效应。
Clin Pharmacol Ther. 1984 Oct;36(4):464-9. doi: 10.1038/clpt.1984.205.
7
The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.一种新型卡前列素衍生物(ZK 36 374)的抗血小板和心血管作用——在体外与前列环素(PGI2)等效。
Naunyn Schmiedebergs Arch Pharmacol. 1981 Jun;316(3):252-5. doi: 10.1007/BF00505658.
8
Primary pulmonary hypertension: natural history and the importance of thrombosis.原发性肺动脉高压:自然病史及血栓形成的重要性
Circulation. 1984 Oct;70(4):580-7. doi: 10.1161/01.cir.70.4.580.
9
Primary pulmonary hypertension. A national prospective study.原发性肺动脉高压。一项全国性前瞻性研究。
Ann Intern Med. 1987 Aug;107(2):216-23. doi: 10.7326/0003-4819-107-2-216.
10
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).原发性肺动脉高压的治疗:静脉注射依前列醇(前列环素)。
Br Heart J. 1987 Mar;57(3):270-8. doi: 10.1136/hrt.57.3.270.